Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2007 December;32(4) > Minerva Endocrinologica 2007 December;32(4):263-73

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS   

Minerva Endocrinologica 2007 December;32(4):263-73

Copyright © 2007 EDIZIONI MINERVA MEDICA

language: English

Cardiovascular risk in women with polycystic ovary syndrome

Cho L. W., Atkin S. L.

Department of Medicine University of Hull, Hull, UK


PDF


Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women that has received an immense amount of attention in the recent years due to the possible associated risk of cardiovascular disease. Women with PCOS demonstrate an adverse cardiovascular profile characteristic of the cardiometabolic syndrome and an established risk of progression to type 2 diabetes. Despite the presence of cardiovascular risk factors and increased surrogate markers of cardiovascular disease, it is unclear if they develop accelerated atherosclerosis. This article summarized the recent development and findings of cardiovascular risk in women with PCOS, and finally the therapeutic options will be discussed.

top of page